Inhibition of platelet-derived growth factor BB-induced expression of glyceraldehyde-3-phosphate dehydrogenase by sodium butyrate in rat vascular smooth muscle cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 12, 1997, Pages 3420-3427

  Ranganna, Kasturi ^a   Yatsu, Frank M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Glyceraldehyde 3 phosphate dehydrogenase; mRNA; Platelet derived growth factor; Smooth muscle cells; Sodium butyrate

Indexed keywords

BUTYRIC ACID; CYCLOHEXIMIDE; DACTINOMYCIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PLATELET DERIVED GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYSIS; CELL PROLIFERATION; CELL SYNCHRONIZATION; ENERGY CONSUMPTION; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; GLYCOLYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT; RECEPTOR UPREGULATION; RNA ANALYSIS; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0031458495     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.12.3420     Document Type: Article

References (21)

1. Owens GK. Control of hypertrophic versus hyperplastic growth of vascular smooth muscles cells. Am J Physiol. 1989;257:H1755-H1765.
2. Schwartz SM, Heimark RR, Majesky MW. Developmental mechanisms underlying pathology of arteries. Physiol Rev. 1990;70:1177-1209.
3. Jackson CL, Schwartz SM. Pharmacology of smooth muscle cell replication. Hypertension. 1992;20:713-734.
4. Ross R. Medical progress: the pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;313:488-500.
5. Clowes AW, Reidy MA, Clowes MM. Kenetics of cellular proliferation after arterial injury: smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
6. McBride W, Lange RA, Hillis LD. Medical intelligence: restenosis after successful coronary angioplasty: pathophysiology and prevention. N Engl J Med. 1988;318:1734-1737.
7. Johnson DE, Hinohara T, Selmon MR, Braden LJ, Simpson, JB. Primary peripheral arterial stenosis and restenosis excised by transluminal atherectomy: a histopathologic study. J Am Coll Cardiol. 1990;15:419-425.
8. Chang MW, Barr E, Seltzer J, Jiang Y, Nabel GJ, Nabel EG, Parmacek MS, Leiden JM. Cytostatic gene therapy for vascular proliferative disorders with constitutively active form of the retinoblastoma gene product. Science. 1995;267:518-522.
9. Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-derived growth factor. Cell. 1986;46:155-169.
10. Kariya K, Kawahara Y, Tsuda T, Fukuzaki H, Takai Y. Possible involvement of protein kinase C in platelet-derived growth factor-stimulated DNA synthesis in vascular smooth muscle cells. Atherosclerosis. 1987;63:251-255.
11. Grotendorst GR, Chang T, Seppae HEJ, Kleinman HK, Martin GR. Platelet-derived growth factor is a chemoattractant for vascular smooth muscles cells. J Cell Physiol. 1981;113:261-266.
12. Ross R, Bowen-Pope DF, Raines EW. Platelet-derived growth factor and its role in health and disease. Phil Trans R Soc Lond. 1990;327:155-169.
13. Cummings JH, Pamare EW, Branch WJ, Naylor CPE, MacFarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28:1221-1227.
14. Scheppach N. Effects of short chain fatty acids on gut morphology and function. Gut. 1994(suppl 1):S35-S38.
15. Cummings JH. Short chain fatty acids in the human colon. Gut. 1981;22:763-779.
16. Ranganna K, Joshi T, Yatsu FM. Sodium butyrate inhibits platelet-derived growth factor-induced proliferation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1995;15:2273-2283.
17. Leder A, Leder P. Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. Cell. 1975;5:319-322.
18. Prasad KN. Butyric acid: a small fatty acid with diverse biological functions. Life Sci. 1980;27:1351-1358.
19. Toribara NW, Sack TL, Gum JM, Ho SB, Shivery JE, Wilson JKV, Kim YS. Heterogeneity in the induction and expression of carcinoembryonic antigen-related antigens in human colon cancer cell lines. Cancer Res. 1989;49:3321-3327.
20. Saito H, Morizane T, Watanabe T, Kagawa T, Miyaguchi S, Kumagai N, Tsuchiya M. Differentiating effect of sodium butyrate on human hepatoma cell lines PLC/PRF/5, HCC-M and HCC-T. Inl J Cancer. 1991;48:291-296.
21. Zoref-Shani E, Lavie R, Bromberg Y, Beery E, Sidi Y, Sperling O, Nordenberg J. Effects of differentiation-inducing agents on purine nucleotide metabolism in an ovarian cancer cell line. Cancer Res Clin Oncol. 1994;120:717-722.